Published in Oncology Business Week, May 30th, 2004
Authors from participating study sites - David Geffen School of Medicine at the University of California, Los Angeles (UCLA); University of Virginia; Texas Oncology PA in Dallas; University of Pittsburgh - and from Altarex Corp. and Unither Pharmaceuticals reported the trial data at the Society of Gynecologic Oncologists 2004 Annual Meeting on Women's Cancer. The first author on the study is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.